United States Hospital Cancer Diagnostics Market Forecasts 2015-2020: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review

DUBLIN, Oct. 27, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/f5ss8p/2015_us_hospital) has announced the addition of the "2015 US Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review" report to their offering.

This new report contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including:

• Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years.
• Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.
• Test volume and sales forecasts for 40 cancer diagnostic procedures performed in US hospitals.
  
• Current instrumentation technologies and feature comparison of leading analyzers.
• Sales and market shares of leading suppliers.
• Emerging diagnostic technologies and their potential market applications.
• Product development opportunities.Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Business opportunities and strategic recommendations for suppliers.

Companies Mentioned

- Abbott

- AdnaGen/Alere

- Agilent Technologies

- Applied Gene Technologies

- Arca Biopharma

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CellSearch

- Cepheid

- Correlogic Systems/Vermillion

- Decode Genetics

- Diadexus

- Diagnocure

- Diasorin

- Eiken Chemical

- Elitech Group

- Epigenomics

- Enterix

- Enzo Biochem

- Exact Sciences

- Fujirebio

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech/Leica

- Kyowa Medex

- Mackay Life Sciences

- Myriad Genetics

- OncoLab

- Roche

For more information visit http://www.researchandmarkets.com/research/f5ss8p/2015_us_hospital

Media Contact: Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com